Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conbercept T&E vs PRN in wet AMD
NCT02802657Phase 4Unknown
- Start
- Sep 2016
- Primary completion
- Sep 2020
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of conbercept in neovascular age-related macular degeneration (NVAMD). Status: unknown.
02
Drugs
conbercept
03
Conditions
neovascular age-related macular degeneration (NVAMD)
Beyond the preview
Go deeper on NCT02802657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02802657.